Hu, M., Xu, Q., Zhang, F., Buckland, K. F., Gao, Y., Du, W., . . . An, Y. Preclinical ex vivo IL2RG gene therapy using autologous hematopoietic stem cells as an effective and safe treatment for X-linked severe combined immunodeficiency disease. KeAi Communications Co., Ltd.
Chicago Style (17th ed.) CitationHu, Mingfeng, et al. Preclinical Ex Vivo IL2RG Gene Therapy Using Autologous Hematopoietic Stem Cells as an Effective and Safe Treatment for X-linked Severe Combined Immunodeficiency Disease. KeAi Communications Co., Ltd.
MLA (9th ed.) CitationHu, Mingfeng, et al. Preclinical Ex Vivo IL2RG Gene Therapy Using Autologous Hematopoietic Stem Cells as an Effective and Safe Treatment for X-linked Severe Combined Immunodeficiency Disease. KeAi Communications Co., Ltd.
Warning: These citations may not always be 100% accurate.